Anuh Pharma Fair Value
Anuh Pharma (ANUHPHR) average fair value is ₹192.11 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹78.44 (+144.92%), fair value range ₹68.32–₹423.15. For live price and a broader fundamental view, visit ANUHPHR stock overview.
Fair Value Analysis Export
ANUHPHR Fair Value vs Current Price — Valuation Summary
ANUHPHR average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore ANUHPHR fundamental worth to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
ANUHPHR Fair Value Analysis — Data Sources & Coverage
Anuh Pharma financial data sources, valuation methods applied and sector benchmarks used. Analyse ANUHPHR shareholder distribution to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
ANUHPHR vs Healthcare Sector Peers — P/E, P/B & Market Cap
Anuh Pharma P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sanofi Consumer Healthca… | SANOFICONR | 43.83 | 27.4 | ₹10,638 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Shopping | SATKARTAR | 29.05 | 5.53 | ₹307 |
| Jeena Sikho Lifecare | JSLL | 40.04 | 22.87 | ₹8,290 |
| Accretion Pharmaceuticals | ACCPL | 10.92 | 1.65 | ₹78 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.